Thomas Condamine

Company: Carisma Therapeutics

Job title: Senior Director, Discovery & Translational Sciences

Seminars:

Harnessing the Unique Features of Macrophage Therapies with CAR Technology (CAR-M) to Fight Solid Tumors 4:00 pm

Maintaining the anti-tumoral polarization within the TME and selective targeting of cancer cells by direct killing activity Phagocytosis of tumor target leads to cross-presentation of tumor antigen and activation of an adaptive immune response Presenting initial data from CT-0508 phase I clinical study, studying the impact of Her2-directed CAR-M in solid tumorRead more

day: Day 1 - Track B - Post Lunch